• Founding director of Access Infinity, a pricing and market access consultancy catering to the pharmaceutical industry with a 28 member team to execute global projects• Access Infinity has offices in London (global office), Hyderabad (APAC office) and New York (US)• 20+ years of total work experience in global markets in biotech and pharmaceutical industry, research management and consulting • 18 years consultancy experience with 14 years focused on global pricing, reimbursement and market access of pharmaceuticals and devices• Client profile interaction with Marketing, Market Access, HEOR, R&D leads at the level of Managers, Directors, Senior Directors, Vice Presidents and CEOs (smaller companies, country affiliates etc.)• In the last 10 years as Head of Pricing and Reimbursement practice won and led 150+ studies, mostly global and contributed to 300 proposals (210 as project proposal lead) • Technical expertise in conducting qualitative and quantitative Payer and KOL research on strategic pricing, evidence gaps analysis, value message and value proposition development, launch pricing strategy, country and indication sequencing, impact of clinical evidence generation on product value assessment, post LoE (loss of exclusivity) price protection strategies, assessment of new products for BD opportunities (in-licensing and out-licensing)• Projects with GSK (25+), Pfizer (20+), Janssen (30+), AZ, Novartis (10+), Otsuka Pharmaceuticals (20+), Intercept (3+), Sage Therapeutics (5+), CSL Behring, Bayer, Baxter, Shire, Takeda, Viropharma, Stiefel, LifeScan, Ferring, Gilead, VIIV, ABPI, APG, Roche, Servier, Lundbeck, SAGE, EUSA and others as clients• Experience of conducting research in 40+ countries.

Art Hub is a global platform connecting musicians and organisers globally.

I have the privelege to be appointed as a Module Leader for health economics module at the University of Cambridge as part of the Masters in Bioscience Enterprise Course. The job includes curriculum development, advising on lecturers, assessment of students and other course related activities.11 years in a row...and still my passion for the course, its students and the university is still the same !

Shifting gears to get some more experience in a Pharma Company in a therapy area with more opportunities to explore novel pricing and market access strategies. After 8 months working with a great team at Lundbeck on CNS diseases, this is an ideal opportunity to which I look forward to contribute having worked in several oncology launches.

A big move from years in consultancy to Pharma to learn new things in a new environment. A very exciting phase and enjoying it. Supporting the global pricing team in developing price policies for different products, price approvals, revenue analysis due to International Price Referencing, business case assessment along with affiliates and market access leads (directors / regional managers). Great GPMA team !!. I loved the experience, the people in the team and ofcourse the challenging projects

A fresh attempt as a co-founder to help pharma companies in building their market access solutions. Pricing and Market access solutions to pharmaceutical companies. Multiple projects related to orphan drugs, oncology, CVD, diabetes and specilised products in European and emerging markets.

Global Head of Pricing and Reimbursent Practice of Double Helix Consulting (DHC). Member of DHC executive committee, responsible for leading projects, business development and strategic development of the company. Recent activities including Chairing an ISPOR symposium on 'Value Based Pricing" and a podium presentation at ISPOR Madrid Nov 2011. Responsible for business development, presentation to clients, strategic leader of global pricing and market access projects, and member of Executive team of Double Helix Consulting. Led 55 projects from 80 proposals in the past 3 years at DHC.

Double Helix Consultancy is part of Double Helix Development and focuses on providing services to pharma and biotech companies in developing their market access, pricing and reimbursement startegies in key markets globally. In addition to the EU5, US markets, the company specialises in market access in emerging markets. Involved in projects in almost 20 markets that includes EU5, US, Canada, Australia, Sweden, The Netherlands, Romania, Russia, Brazil, Mexico, Turkey and Saudi Arabia. Extremely exciting !!

PriceSpective is a pharmaceutical pricing consultancy in London. The company has expertise in drug pricing strategy and reimbursement in EU and US. The clients include all the top 10 pharmaceutical companies as well as Biotechs.

Responsible for developing a tool based on value based pricing of pharmaceuticals considering the the perspectives of different stakeholders

Common Fund for Commodities, The NetherlandsDanish International Development Agency (DANIDA), DenmarkMarine Resources Dev. Pvt. Ltd, Bangkok, ThailandBirla Group of Industries, Thailand Buhler Group, SwitzerlandVeda Biotech Co. Ltd, Hyderabad, India Inspira Life Sciences Co. Ltd., Hyderabad, IndiaMember of the International Scientific Advisory Board